1. Interleukin-17 induces rapid tyrosine phosphorylation and activation of raf-1 kinase in human monocytic progenitor cell line U937.
- Author
-
Subramaniam SV, Pearson LL, and Adunyah SE
- Subjects
- Enzyme Activation drug effects, Humans, Killer Cells, Natural drug effects, Phosphorylation, Phosphotyrosine analysis, Recombinant Proteins, Signal Transduction drug effects, Interleukin-17 pharmacology, Proto-Oncogene Proteins c-raf metabolism, Tyrosine metabolism, U937 Cells drug effects
- Abstract
Interleukin-17 is a T cell derived pro-inflammatory cytokine exhibiting multiple biological activities in a variety of cells and believed to fine tune all general phases of hematopoietic response. However, the signaling mechanism of this novel cytokine remains unknown. The purpose of this study was to determine whether Interleukin-17 induces tyrosine phosphorylation of proteins and to find out whether the raf-1 kinase signaling pathway is involved in mediating its signaling. Using immunoblotting and immunocomplex kinase assays, we report that the early signaling events triggered by rhIL-17 involves rapid tyrosine phosphorylation of several cellular proteins including raf-1 within 0.5 to 30 min. Optimal stimulation of tyrosine phosphorylation was observed with 0.5 to 1.0 ng/ml of Interleukin-17. Further, Interleukin-17 stimulates rapid activation of raf-1 kinase. These findings provide the first evidence that the mechanism of IL-17 signaling involves rapid tyrosine phosphorylation and activation of raf-1 serine/threonine kinase., (Copyright 1999 Academic Press.)
- Published
- 1999
- Full Text
- View/download PDF